期刊文献+

丙肝病毒核心基因克隆载体pGEM-HCV/core的构建 被引量:1

Construction of cloning plasmid pGEM-HCV/core containing the core gene of HCV
下载PDF
导出
摘要 目的构建丙肝病毒核心基因克隆载体pGEM-HCV/core,为进一步研究外部引导序列(external guide sequence,EGS)引导核糖核酸酶P在RNA水平阻断丙肝病毒核心基因的表达做好前期基础。方法将含HCV全长基因的pBRTM/HCV1-301l质粒于大肠杆菌JMl09内扩增;提取pBRTM/HCV1-301l质粒;从pBRTM/HCV1-301l质粒中PCR扩增出HCV核心基因片段并将其插入pGEM-3Z克隆载体;以得到重组的pGEM-HCV/core克隆载体;最后EcoR I and Hind III双酶切鉴定HCV核心基因克隆载体。结果pGEM-HCV/core克隆载体经双酶切、凝胶电泳证明插入片段与HCV核心基因片段大小相符;经测序证明其插入序列与HCV core基因序列一致。结论成功构建了HCV核心基因的克隆载体pGEM-HCV/core。 Objective To construct the clone plasmid containing the core gene of HCV, preparing for the research of blockage of the expression of HCV core gene guided by EGS at the level of mRNA. Methods After expanding plasmid pBRTM/HCV1-3011 ( containing the whole genome of HCV) through E. coli JM109. The core gene with pBRTM/HCV1-3011 is amplified with PCR as the template; The core segment was inserted into the clone plasmid pGEM-3Z. Plasmid pGEM - HCV/core was digested with EcoR I and Hind III. Results The PCR result of HCV core has correct size and sequences. Conclusion The clone plasmid pGEM-HCV/core has successfully been constructed.
出处 《广东药学院学报》 CAS 2008年第2期185-187,190,共4页 Academic Journal of Guangdong College of Pharmacy
基金 广州市科技局基金资助项目(2005J1-C0291)
关键词 HCV core基因 载体 EGS HCV core gene vector EGS
  • 相关文献

参考文献2

二级参考文献28

  • 1Lewin AS, Hauswirth WW. Ribozyme gene therapy: Applications for molecular medicine. Trends Mol Med, 2001, 7(5): 221-228.
  • 2Kijima H, lshida H, Ohkawa T, Kashani-Sabet M, Scanlon KJ. Therapeutic applications of ribozymes. Pharmacol Ther, 1995, 68(2): 247-267.
  • 3Raj SML, Liu FY. Engineering of RNase P ribozyme for gene-targeting applications. Gene, 2003, 313(2003): 59-69.
  • 4Trang P, Hsu AW, Liu FY. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate. Nucleic Acids Res, 1999, 27(23): 4590-4597.
  • 5Kilani AE Trang P, Jo S, Hsu A, Kim J, Nepomuceno E, Liou K et al.RNase Pribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture. J Biol Chem, 2000, 275(14): 10611-10622.
  • 6Trang P, Lee M, Nepomuceno E, Kim J, Zhu H, Liu FY. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.Proc Natl Acad Sci USA, 2000, 97(1 l): 5812-5817.
  • 7Baldanti F, Lurain N, Gerna G. Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Hum Immunol, 2004, 65(5):403-409.
  • 8Trang P, Kim K, Liu F. Developing RNase P ribozymes for gene-targeting and antiviral therapy. Cell Microbiol, 2004, 6(6): 499-508.
  • 9Zou J, Gong ZX. lnhibtion of replication of goose paramyxovirus SF02 by hammerhead ribozyme targeting to the SF02 F mRNA in chicken embryo fibroblasts. Acta Biochim Biophys Sin, 2003, 35(9): 801-805.
  • 10Zheng WC, Qi GR. tRNA-embedded hammerhead ribozymes mediate destruction of HBV (subtype adr) in vitro. Acta Biochim Biophys Sin,1998, 30(5): 432-438.

共引文献6

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部